Insider Trading Activity ResMed Inc. (NYSE:RMD) – CFO Sold 1,250 shares of Stock

ME Staff
-
0

Insider Trading Activity For ResMed Inc. (NYSE:RMD)

Brett Sandercock , CFO of ResMed Inc. (NYSE:RMD) reportedly Sold 1,250 shares of the company’s stock at an average price of 77.49 for a total transaction amount of $96,862.50 SEC Form

Insider Trading History For ResMed Inc. (NYSE:RMD)

  • On 8/8/2012 Michael J Farrell, Insider, sold 30,000 with an average share price of $35.58 per share and the total transaction amounting to $1,067,400.00.View SEC Filing
  • On 2/4/2013 Robert Andrew Douglas, COO, sold 8,000 with an average share price of $44.14 per share and the total transaction amounting to $353,120.00.View SEC Filing
  • On 5/8/2013 Brett Sandercock, CFO, sold 28,000 with an average share price of $48.97 per share and the total transaction amounting to $1,371,160.00.View SEC Filing
  • On 5/13/2013 Michael A Quinn, Director, sold 15,000 with an average share price of $50.94 per share and the total transaction amounting to $764,100.00.View SEC Filing
  • On 5/22/2013 John P Wareham, Director, sold 18,000 with an average share price of $50.20 per share and the total transaction amounting to $903,600.00.View SEC Filing
  • On 5/24/2013 Christopher G Roberts, Director, sold 20,000 with an average share price of $49.45 per share and the total transaction amounting to $989,000.00.View SEC Filing
  • On 6/3/2013 Robert Andrew Douglas, COO, sold 8,000 with an average share price of $47.96 per share and the total transaction amounting to $383,680.00.View SEC Filing

    • Analyst Ratings For ResMed Inc. (NYSE:RMD)
    These are 4 Sell Ratings, 5 Hold Ratings, 2 Buy Ratings .
    The current consensus rating for ResMed Inc. (NYSE:RMD) is Hold (Score: 1.82) with a consensus target price of $62.57 , a potential (19.24% downside)

    Analyst Ratings History For ResMed Inc. (NYSE:RMD)

    • On 9/24/2015 Goldman Sachs Group, Inc. (The) Upgraded rating Neutral to Conviction-Buy
    • On 10/6/2015 Deutsche Bank AG Upgraded rating Sell to Hold with a price target of $53.00 to $56.00
    • On 4/27/2016 Piper Jaffray Companies Downgraded rating Overweight to Neutral with a price target of $65.00 to $57.00
    • On 4/27/2016 Macquarie Upgraded rating Underperform to Neutral
    • On 8/29/2016 Northland Securities Set Price Target of rating Sell with a price target of $50.00
    • On 1/24/2017 Barclays PLC Boost Price Target of rating Underweight with a price target of $55.00 to $60.00
    • On 2/6/2017 Canaccord Genuity Reiterated Rating Hold with a price target of $59.00

    Dividend Information For ResMed Inc. (NYSE:RMD)
    ResMed Inc. (NYSE:RMD) pays an annual dividend of Community Ranking: with a yield of 1.70% and an average dividend growth of 14.50% (3 Year Average).

    Dividend History For ResMed Inc. (NYSE:RMD)

  • On 1/25/2013 ResMed Inc. announced a quarterly dividend of $0.17 1.41% with an ex dividend date of 2/14/2013 which will be payable on 3/19/2013.
  • On 4/29/2013 ResMed Inc. announced a quarterly dividend of $0.17 1.44% with an ex dividend date of 5/17/2013 which will be payable on 6/18/2013.
  • On 8/2/2013 ResMed Inc. announced a quarterly dividend of $0.25 2.09% with an ex dividend date of 8/16/2013 which will be payable on 9/17/2013.
  • On 10/25/2013 ResMed Inc. announced a quarterly dividend of $0.25 2.02% with an ex dividend date of 11/15/2013 which will be payable on 12/18/2013.
  • On 1/24/2014 ResMed Inc. announced a quarterly dividend of $0.25 2.28% with an ex dividend date of 2/14/2014 which will be payable on 3/19/2014.
  • On 4/24/2014 ResMed Inc. announced a quarterly dividend of $0.25 2.11% with an ex dividend date of 5/16/2014 which will be payable on 6/17/2014.
  • On 8/1/2014 ResMed Inc. announced a quarterly dividend of $0.28 2.25% with an ex dividend date of 8/19/2014 which will be payable on 9/18/2014.

    • Recent Trading Activity for ResMed Inc. (NYSE:RMD)
    Shares of ResMed Inc. closed the previous trading session at 71.78 down -5.70 -7.36% with 1,017,605 shares trading hands.